Fingerprint
Dive into the research topics of 'Prognostic impact of circulating methylated homeobox A9 DNA in patients undergoing treatment for recurrent ovarian cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Prognostic impact of circulating methylated homeobox A9 DNA in patients undergoing treatment for recurrent ovarian cancer
Louise Faaborg*, Rikke Fredslund Andersen, Marianne Waldstrøm, Jon Røikjær Henriksen, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
*Corresponding author for this work
- IRS - Lillebælt Hospital, Research Unit of Oncology (Vejle)
- Department of Regional Health Research
- IRS - Lillebælt Hospital, Research Unit of Biochemistry and Immunology (Vejle)
- IRS - Lillebælt Hospital, Research Unit of Clinical Pathology (Vejle)
- KI, OUH, Research unit of Oncology (Odense)
- Department of Clinical Research
Research output: Contribution to journal › Conference article › Research › peer-review
49
Downloads
(Pure)